Bisoprolol Market Share 2022 Growth Challenges, Opportunities and Future Trends 2028

The global bisoprolol market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Bisoprolol is a beta-blocker. It affects the heart and circulation of blood flow through arteries and veins and is used for the treatment of hypertension (high blood pressure). The major factor driving the demand for bisoprolol is the increasing prevalence of hypertension across the globe. According to the Center for Disease Control and Prevention, nearly half of adults or 47%, or 116 million have hypertension which is defined as a systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension in the US. Additionally, about 1 in 4 adults (24%) with hypertension have their condition under control, and about half of the adults or 45% or 37 million with uncontrolled hypertension have a blood pressure of 140/90 mmHg or higher in the US. Furthermore, about 34 million adults are recommended to take medication and about two out of three of this group or 19 million have a blood pressure of 140/90 mmHg or higher. Hence, the increasing prevalence of hypertension is driving the demand for bisoprolol for treatment which in turn is driving the growth of the market.

To Request a Sample of our Report on Bisoprolol Market: https://www.omrglobal.com/request-sample/bisoprolol-market

Some major players in the market include Novartis International AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Glenmark announced that it has received final approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg from the US Food & Drug Administration (FDA). It is the generic version of Ziac1 Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, of Teva Pharmaceutical.

`Market Coverage

• The market number available for - 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Novartis International AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Bisoprolol Market is Available @ https://www.omrglobal.com/industry-reports/bisoprolol-market

Global Bisoprolol Market Report by Segment

By Type

• Capsule

• Tablet

By Application

• High Blood Pressure

• Angina pectoris

• Coronary Heart Disease

• Others

Global Bisoprolol Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.